Overview
EMS Chemie Holding AG, a Swiss specialty chemicals producer, saw its shares climb more than 2% after the company raised its full‑year net‑sales forecast while reporting improved margins in the first half of 2026.
Financial Performance (Six months to 30 June 2026)
- Operating income (EBIT) rose to CHF 310 million, up from CHF 296 million a year earlier, lifting the EBIT margin to 30.6% from 29.1%.
- EBITDA increased 3.9% to CHF 336 million, with the EBITDA margin expanding to 33.2% versus 31.7% in the prior period.
- Net sales in Swiss‑franc terms declined 0.8% to CHF 1.01 billion from CHF 1.02 billion, but in local currencies sales were up 4.5%.
- First‑half operating profit grew 4.7% year‑on‑year, driven by cost discipline and higher contribution from specialty‑product lines.
Operational Context
- The company highlighted a challenging backdrop of inconsistent U.S. trade policy, escalating conflict in the Middle East, and a significantly stronger Swiss franc.
- Higher raw‑material costs were mitigated through what EMS described as “unavoidable sales price adjustments.”
- Products sold in the United States are produced almost entirely locally or qualify as “important specialties” exempt from U.S. customs duties; EMS reported no business relationships in the Middle East.
- Demand for metal‑replacement and energy‑saving applications was identified as a key profit driver, with electric‑vehicle, robotics and data‑centre markets cited as emerging growth areas.
Guidance and Outlook
- For the full year 2026, EMS slightly raised its net‑sales forecast, although it still expects revenue to be marginally below the 2025 level because of adverse currency effects.
- Full‑year operating income is projected to be slightly above the prior‑year figure and remains unchanged from the earlier guidance provided.
Dividend Proposal
- The board intends to propose a total dividend of CHF 18.40 per share at the Annual General Meeting scheduled for 8 August, comprising an ordinary dividend of CHF 14.65 and an extraordinary dividend of CHF 3.75.
- This represents an increase from the total dividend of CHF 17.25 per share paid in the previous year.
Market Reaction
- Following the announcement, EMS Chemie’s stock (ticker EMSN) rose approximately 2.6% on the day of the release.